Study Details

Back
Study ID 3652-CL-0018
Study Title A phase 2, randomized, double-blind, placebo-controlled, parallel group, adaptive, combined proof of concept and dose-finding study to investigate efficacy, safety, pharmacodynamics and pharmacokinetics of ASP3652 in the treatment of female patients with Bladder Pain Syndrome/Interstitial Cystitis
Clinicaltrials.gov Identifier NCT01613586
Compound Name ASP3652
Medical Indication or Disease Bladder pain
Study Sponsor Astellas Pharma Global Development - Europe
Collaborator Not Applicable
Study Start Date 31-May-2012
Study Completion Date 18-Mar-2014
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS